Xeris Biopharma Holdings, Inc. (XERS)
7.805
+0.50
(+6.77%)
USD |
NASDAQ |
Dec 31, 11:05
Xeris Biopharma Holdings Market Cap: 1.295B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 72.84M |
| Assertio Holdings, Inc. | 55.38M |
| Amneal Pharmaceuticals, Inc. | 4.005B |
| NovaBay Pharmaceuticals, Inc. | 711.96M |
| Palatin Technologies, Inc. | 13.27M |
Market Cap Related Metrics
| PS Ratio | 4.682 |
| Price to Free Cash Flow | 124.92 |
| Price | 7.805 |
| Earnings Yield | -1.32% |
| Operating PE Ratio | 127.13 |